Alzheimer Disease Clinical Trials in Taichung
2 recruitingTaichung, Taiwan
Showing 1–2 of 2 trials
Recruiting
Phase 3
A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)
DementiaBrain DiseasesCentral Nervous System Diseases+6 more
Eli Lilly and Company1,500 enrolled141 locationsNCT05508789
Recruiting
Not Applicable
Causal Effect of Coenzyme Q10 Nutrition and Cognitive Dysfunction in the Metabolic Storm (Hyperglycemia and Sarcopenia) and Brain-derived Neurotrophic Factor
Alzheimer DiseaseMild Cognitive ImpairmentHyperglycemia+1 more
Chung Shan Medical University100 enrolled1 locationNCT06040905